Diana R. Tomchick
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
269
Citations
13,145
Est. group size
—
Recurring co-author estimate
Active years
40
Publishing since 1987
Diana R. Tomchick works on determining the three-dimensional structures of proteins and enzymes to understand how they function and malfunction in disease, using techniques such as X-ray crystallography. Her collaborative work spans diverse biological problems, including bacterial immune systems, metabolic and lipid-related genetic disorders, cell signaling proteins, and drug target discovery for conditions like malaria and heart disease. This structural biology expertise is applied across many collaborative projects with other labs studying specific diseases and biological pathways.
Publication output has fluctuated over the last decade, with a peak in 2020, a marked slowdown between 2021-2023, and a partial rebound in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- TIR-like NADases act in bacterial immunity and the RNA vault
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Bacterial ubiquitin ligase engineered for small molecule and protein target identification
The EMBO Journal · 2026
- Leptin as a key driver for organ fibrogenesis
Science Advances · 2025
- A recurrent ACAA2 variant causes a dominant syndrome of lipodystrophy, lipomatosis, infantile steatohepatitis, and hypoglycemia
Journal of Clinical Investigation · 2025
- Bacterial ubiquitin ligase engineered for small molecule and protein target identification
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- ACAD10 encodes two orphan enzymes in the ether lipid biosynthetic and salvage pathways
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- A domain-swapped CaMKII conformation facilitates linker-mediated allosteric regulation
Nature Communications · 2025
- Erratum. Gain of Function <i>NOTCH3</i> Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways. Diabetes 2025;74:427–438
Diabetes · 2025
- Editorial Expression of Concern: Munc13 C2B domain is an activity-dependent Ca2+ regulator of synaptic exocytosis
Nature Structural & Molecular Biology · 2025
- Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria Chemoprevention
Journal of Medicinal Chemistry · 2024
- Identification of FDA-approved drugs that induce heart regeneration in mammals
Nature Cardiovascular Research · 2024
- Biochemical and structural insights into a 5’ to 3’ RNA ligase reveal a potential role in tRNA ligation
Proceedings of the National Academy of Sciences · 2024
- Gain of Function <i>NOTCH3</i> Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways
Diabetes · 2024
- <i>Pseudomonas</i> effector AvrB is a glycosyltransferase that rhamnosylates plant guardee protein RIN4
Science Advances · 2024
- A domain-swapped CaMKII conformation facilitates linker-mediated allosteric regulation
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×10
- Acta Crystallographica Section A Foundations and Advances×8
- Proceedings of the National Academy of Sciences×6
- eLife×5
- Journal of Biological Chemistry×5
- V. Jo Davisson
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Mark Cushman
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Sandip Vibhute
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Chad Bennett
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Iredia D. Iyamu
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile